Edition:
United States

Biodel Inc (BIOD.OQ)

BIOD.OQ on NASDAQ Stock Exchange Capital Market

0.44USD
4:00pm EDT
Change (% chg)

$-0.02 (-4.40%)
Prev Close
$0.46
Open
$0.46
Day's High
$0.46
Day's Low
$0.43
Volume
329,790
Avg. Vol
119,343
52-wk High
$1.07
52-wk Low
$0.22

BIOD.OQ

Chart for BIOD.OQ

About

Biodel Inc. is a specialty biopharmaceutical company. The Company focuses on the development and commercialization of treatments for diabetes. The Company is engaged in developing product candidates by applying its formulation technologies to existing drugs. The Company is engaged in developing room temperature stable glucagon... (more)
No analyst recommendations are available for BIOD.OQ.

Overall

Beta: 2.07
Market Cap(Mil.): $28.87
Shares Outstanding(Mil.): 64.15
Dividend: --
Yield (%): --

Financials

  BIOD.OQ Industry Sector
P/E (TTM): -- 41.55 39.69
EPS (TTM): -0.31 -- --
ROI: -77.25 -9.57 14.44
ROE: -79.35 -9.91 15.49

BRIEF-Biodel files proxy statement related to proposed merger with Albireo

* Files proxy statement related to proposed merger between Biodel and Albireo Limited Source: (http://bit.ly/29RsDuP ) Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Jul 13 2016

BRIEF-Biodel Inc reports Q2 loss per share $0.09

* Biodel reports second quarter fiscal year 2016 financial results

May 09 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$104.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.